Modern Diagnostic IPO ends today as final-day subscription and GMP remain in focus

The Modern Diagnostic IPO, which opened for subscription on December 31, 2025, has seen strong investor demand, with the issue subscribed over 28.77 times by the end of Day 2, driven mainly by robust participation from non-institutional investors and retail bidders. The NII portion was oversubscribed 39.61 times, while retail investors subscribed 33.85 times, and QIBs booked their segment 8.94 times, as per BSE data. Positive sentiment is also reflected in the grey market, where shares are trading at a premium of ₹14, indicating a potential listing price of around ₹104. The ₹36.89 crore IPO is a fully fresh issue, with proceeds earmarked for medical equipment purchases, working capital needs, partial debt repayment, and general corporate purposes.